Epidemiologic studies suggest an independent positive association of elevated serum uric acid with essential hypertension. However, to date, limited information is available in the old population. In the present study, we included 832 unrelated Chinese nonagenarians/centenarians (269 men and 563 women; ranged in age from 90 to 108 years (mean, 94.6±4.0)). The mean serum uric acid level was 320 lmol l À1 (standard deviation 87 lmol l
Introduction
Hypertension, as a common age-related disorder, is a major contributor to myocardial infarction, heart failure, stroke and renal failure. According to the report of 2000 US Census Bureau Annual Resident Population, the estimated prevalence rates of hypertension in US adult population are 6.0, 16.0, 31.0, 48.0, 65.1 and 77.6% in 18-34, 35-44, 45-54 , 55-64, 65-74 and^75 years age groups, respectively. 1 The concept that uric acid may be involved in hypertension is not a new one, which has been reported more than a century ago. [2] [3] [4] [5] More than a dozen of prospective and cross-sectional observational studies have demonstrated that the elevated serum uric acid (SUA) is a potential independent risk factor for the development of hypertension in the general population. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Common to each of these studies, however, is the relatively young age of the participants. The average age of each population was under 50 years, only a few of studies included subjects over 60 years of age. 6, 13, [15] [16] [17] Recently, one new evidence of the Health Professionals' Followup Study (HPFS) 20 failed to identify the association between serum uric acid level and the risk for incident hypertension among elderly (range 61-81 years old). In the older population, the association between serum uric acid and hypertension is still unknown. Therefore, we conducted this study to examine whether the serum uric acid is associated with primary hypertension in a large communitybased sample of unrelated Chinese nonagenarians/ centenarians.
Subjects and methods

Study subjects
On the basis of the Dujiangyan (located in Sichuan province, southwest China) 2005 census, a crosssectional study for age-related diseases was conducted in 870 long-lived subjects (^90 years), which is a part of the Project of Longevity and Aging in Doujiangyan (PLAD). The PLAD aimed to investigate the relationship between environments, lifestyle, genetic, longevity and age-related diseases. Volunteers were examined by trained professional physicians according to basic health criteria. And the results were filled in the standard form, especially age-related diseases: cancer, type 2 diabetes, hypertension, heart failure, chronic obstructive pulmonary disease, Alzheimer's disease and Parkinson's disease and so on. In this analysis, long-lived subjects with cancer, secondary hypertension, severe heart failure, terminal stage of chronic obstructive pulmonary disease, Alzheimer's disease and Parkinson's disease were excluded. We also excluded subjects who self-reported use of drugs affecting uric acid, such as allopurinol or uricosuric agents, losartan, which have been shown in humans to decrease serum uric acid, 21, 22 and diuretic, which could increase serum uric acid concentration. The study population ultimately consisted of 832 long-lived subjects. Informed consents were obtained from all participants (as well as their legal proxies). The Research Ethics Committee of the Sichuan University approved the study.
Data collection and measurements
Trained study personnel made the face to face interviews, participants were underwent a standardized enquiry for the self-reported medical history, medication, standardized physical examination, anthropometric measurements and a 12-lead electrocardiogram, based on the prepared questionnaire for the medical record. We obtained information: age, gender, weight (kilograms), height (centimeters), waist and hip circumference (centimeters, waist circumference was measured at the midpoint between the lower rib margin and the iliac crest, and hip circumference was measured at the trochanter level), current tobacco smoking, tea drinking, alcohol consumption and alcohol, smoking history, dietary habits, mini-mental state examination and other items. Body mass index (kg m À2 , BMI) was calculated as body weight in kilograms divided by height in metres squared, and waist-to-hip ratio (WHR) was also calculated. Venous blood samples were collected after an overnight fast (at least 8 h) for measurement of plasma glucose, plasma lipids, serum uric acid, serum creatinine (SCr) and other biochemistry indicators. Sitting or recumbent position, right arm blood pressure (BP) was measured twice to the nearest 2 mm Hg using a standard mercury sphygmomanometer (phases I and V of Korotkoff) by trained nurses or physicians. The mean value of two measurements was used to calculate systolic BP (SBP) and diastolic BP (DBP), and theSBP and DBP were calculated as the mean of right and left arm values in exceptional subjects. 23 Metabolic syndrome (MetS) was identified by the criteria of the International Diabetes Federation. 24 Biochemical parameters including fasting plasma glucose (FPG), total cholesterol (TC), triglycerides (TGs), highdensity lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), SUA and SCr were determined by standard laboratory techniques. Serum uric acid levels were determined by the uricase-peroxidase method. 25 Hyperuricemia was defined as a serum uric acid concentration 4420 mmol l À1 in men and 4360 mmol l À1 in women, in agreement with the normal value provided by our clinical laboratory.
Statistical analysis
All of the statistical analyses for this study were performed with the SPSS for Windows software package, version11.5 (SPSS Inc., Chicago, IL, USA). All clinical continuous variables, skew values were log-transformed to induce normality of distribution, are presented as means ± standard deviation (M±s.d.). Current smoker, alcohol consumption and alcohol, smoking history and so on, for each group, are presented as dichotomous variables. Significance testing of the difference between the two groups was analysed using unpaired Student's t-test, w 2 -test, and correlations were assessed by Pearson's coefficients. The analysis of variance (ANOVA) was used to test for differences owing to covariates among the different arterial BP groups. Finally, because serum uric acid levels are correlated with MetS, [26] [27] [28] and in an attempt to explore the independent association between SUA and hypertension, Multivariate logistic analyses were performed to evaluate the association between potential risk factors, including other four factors of MetS, and hypertension. We calculated the 95% confidence interval (CI) for each odds ratio. P-value o0.05 was considered to be statistically significant, and all of the P-values are two sides.
Results
Baseline characteristics and prevalence of hyperuricemia and hypertension Among the 832 volunteers, mean age was 94.6 years (s.d. 4 .0 years, range 90-108 years) and 563 (68%) were women, including 81 centenarians. A total of 90% of subjects lived in the countryside. The mean SUA level for the old population was 320 mmol l À1 (s.d. 87 mmol l À1 , range 24-846 mmol l À1 ). Men had a significantly higher SUA levels than women (343±91 vs 310±84 mmol l À1 , Po0.001). The prevalence of hyperuricemia was 21% in the whole population, 20% and 22% in men and women, respectively. And the prevalence of hypertension was 57% (men 52%, women 59%); there were 362 (77%) ISHs and 12 (2.5%) IDHs. Mean pulse pressure was 67 mm Hg (s.d. 21 mm Hg). Nearly 83% (390) of the participants with hypertension were first diagnosed. Obesity (BMI^30) has been associated with both hypertension and hyperuricemia; however, only two elderly obesity were found. A total of 18 hypertensive subjects, physicians' diagnosis before, take the anti-hypertensive medications regularly, so the BP was not well controlled in our hypertensive participants. A total of 85 participants with metabolic syndrome (men: 9; women: 76) were found, among them, 70 (men: 6; women: 64) metabolic syndrome subjects were with hypertension. The main demographic, clinical and laboratory characteristics of the 832 subjects, according to BP and gender, are shown in Table 1 .
Correlations between serum uric acid and clinical variables SUA demonstrated multicollinearity with several physical and biochemical markers (Table 2) . Highly significant correlations (with coefficients r ¼ 0.353, 0.546, in women and men, respectively, Po0.001) existed in both genders between log-transformed SCr and SUA. SUA correlated significantly with waist circumference and hip circumference in all population, but the correlation between SUA and WHR failed to reach statistical significance. A strong significant correlations was found between logtransformed FPG and SUA (r ¼ 0.242, Po0.001) in men, whereas it was weakened (r ¼ 0.070, P ¼ 0.013) in women. In addition, weaker correlations were noted between serum uric acid and log-transformed BMI, TGs in women (r ¼ 0.107, 0.151) and log-transformed HDL-C concentrations (r ¼ À0.191, À0.121 in men and women, respectively).
Serum uric acid levels and arterial blood pressure classifications Serum uric acid levels for populations were shown by BP classifications in each gender group of the cohort ( Figure 1 a: men, b: women). In male subjects, Values were log-transformed before analysis. In the testing, a P value o0.0023 calculated with Bonferroni's adjustment was considered to be statistically significant.
Uric acid and elderly hypertension Z Lu et al when compared with subjects with normal BP, serum uric acid levels were significantly lower in subjects with stage 2 hypertension (P ¼ 0.027) by analysis of covariance. No other difference was observed for serum uric acid levels in six male subgroups. A non-significant increase was found for serum uric acid levels among female hypertensive subjects. Furthermore, the association between uric acid and systolic/diastolic hypertension, ISH, IDH and normal BP were investigated. After univariate ANOVA analysis, the results were also negative ( Figure 2 ). Finally, in the analysis of mean uric acid in those subjects with metabolic syndrome vs those normal BP or hypertensives without metabolic syndrome, higher serum uric acid levels were found in the metabolic syndrome groups (Figure 3 ).
Serum uric acid and risk for hypertension/isolated systolic hypertension
We further assessed whether a higher level of serum uric acid was associated with an increased risk for hypertension (Table 3) or increased risk for ISH (Table 4) . After adjustment for age, BMI, WHR, smoking, alcohol, tea, FPG, TGs, TC, HDL-C, LDL-C, SCr, the odds ratios for hypertension were 0.67 (95% CI, 0.33-1.21) and 1.36 (95% CI, 0.88-2.22) in men and women, respectively, with the highest quartile of serum uric acid level compared with the lowest quartile of serum uric acid level. And the multivariable adjustment odds ratios for ISH also could not found any association (Table 4) .
Discussion
On the basis of cross-sectional observations in community-dwelling older persons, we found no direct association between SUA levels and hypertension in nonagenarians/centenarians, after adjustment for age, BMI, WHR, smoking, tea, alcohol, FPG, TGs, TC, HDL-C, LDL-C and SCr.
To the best of our knowledge, no other researchers have specially evaluated the association between SUA and hypertension in the oldest old (^85 years) so far. This study extends the findings of previous studies, because the average age of this study is older than the average age of any previous study by three decades (mean age: 94 vs %61 years), which includes subjects 460 years. 6, 13, [15] [16] [17] 20 To date, the association between elevated SUA and risk for hypertension in the old still remains indefinite. A total of 13 prospective longitudinal observational studies for the association between elevated SUA and risk for hypertension are presented in Table 5 . Although there are some potential unadjusted confounders, such as impaired renal function, endocrine factors, insulin resistance, diuretic use, alcohol use, baseline BP measurement and different ethnic groups, previous studies including big samples clearly showed: with the aging process, the risk for hypertension by the elevated SUA levels are attenuated. A good example is Framingham Heart Study (mean age 48.7 years) conducted by Sundstrom et al. 15 After 4 years' follow-up, the result of multivariable analyses suggested that a 1 s.d. (77 mmol l À1 ) increase in SUA concentration was associated with 17-29% increased odds of developing hypertension. However, in secondary analyses extending follow-up to 12 years (when nearly half of the participants became old) the outcome of risk became statistically insignificant. Furthermore, the latest study-HPFS, 20 suggested that SUA was not associated with an increased risk for incident hypertension among older men (61-84 years). The findings for our study are consistent with the findings of HPFS. Values have been log-transformed. A P-valueo0.0038 calculated with Bonferroni's adjustment was considered to be statistically significant.
Uric acid and elderly hypertension Z Lu et al
Several mechanisms have been proposed to explain an association between SUA and essential hypertension, including impairment of vascular nitric oxide activity, 29 decreased production of nitric oxide 30 and activation of the renin-angiotensin system (RAS), 31, 32 stimulation of vascular smooth muscle cell proliferation. 33, 34 In addition, elevated SUA concentration is also associated with insulin resistance, 35 high triglyceride levels, 36 proinflammatory, chronic inflammation 37, 38 and increased arterial stiffness, 39 all of which may affect the development of hypertension. 40 These mechanisms may be less important when hypertension develops at an older age. Several experimental studies further demonstrated that hyperuricemia caused pre-glomerular vascular disease through a BP-independent pathway, 41 and once vascular changes were established, the hypertension was driven by the kidney, along with the activation of the renal RAS by the increased age. 42 It is not surprising that the association between uric acid levels and BP weakens in the old. 33 The presentation of the earlier Framingham study, that the correlation of uric acid levels with BP was attenuated in the study population as they aged, is consistent with these data. 43, 44 In 1993, Casiglia et al. 45 observed that Uric acid and elderly hypertension Z Lu et al blood uric acid is a strong predictor for mortality in very old subjects aged 80 years or over, but the arterial hypertension, which has a strong risk potential in young adults, was a very poor predictor of mortality. It implicated that blood uric acid may affect mortality through other mechanisms, rather than by aggravating hypertension, and to some extent, the correlation between serum uric acid and hypertension may be attenuated by other factors in the very old subjects. Furthermore, it is another evidence that with the aging process, the age-related stiffening of the aorta may be critical in the old hypertension. 46 Intriguingly, SUA is also an effective anti-oxidant. 47 In a human research conducted by Rosell et al. 48 demonstrated that serum urate is a strong determinant of the anti-oxidant capacity, and SUA possibly is the most abundant aqueous anti-oxidant, accounting for up to 60% of serum-free radical scavenging capacity. 49 Nieto et al. 50 suggested that hyperuricemia may be a compensatory mechanism to counteract oxidative damage related to atherosclerosis and aging in humans. In addition, lifestyle and a genetic background are potentially protective against the age-related diseases, including hypertension, among long-lived subjects. 51 It is not surprising that the association between SUA and essential hypertension may be attenuated in nonagenarians/centenarians. Furthermore, it is possible that the association between serum uric acid and hypertension involves complex relations between serum uric acid and different pathogenetic or compensatory pathways in elderly subjects, and the unknown relative importance of these pathways in different age populations may be an explanation for the inconsistent findings in the literature. 19 Finally, it is of note that serum uric acid levels are correlated with MetS, [26] [27] [28] and our results also suggest that higher uric acid concentration was found in the subjects with MetS. Therefore, the adjustment for metabolic variates, including FPG, TG and cholesterol levels, to a certain extent, may substantially attenuated the positive association of uric acid and hypertension. However, a new consensus statement from the International Diabetes Federation 24 suggested that: although the pathogenesis of the MetS and each of its components still not fully elucidated, two features-insulin resistance and abnormal fat distribution (central obesity) appear to stand out as potential causative factors. Of note, the essential relationship between metabolic syndrome and hypertension is insulin resistance/hyperinsulinemia. And, when it comes to our participants, the mean BMI is 19, the mean WHR is 0.9, and Barbieri and co-workers 51 were also able to document a significant reduction of insulin resistance in subjects of 90 and 100 years than that of young old. These accumulated evidence implicate that most of hypertension in our study are relatively independent metabolic syndrome. Therefore, adjustment for the other metabolic derangements could not substantially attenuate the positive association of uric acid and hypertension. Our study has some limitations that deserve mention. First, because of the cross-sectional nature of this study, a single uric acid level as reflecting the overall uric acid balances, subjects may change their diets and the conditions related to elevated SUA concentrations. However, the lifestyles and food habits of the nonagenarians/centenarians are relatively stable and similar. Second, there was the gender imbalance in our population, which is the common characteristic of long-lived subjects in the world. Although there were in total 1115 long-lived subjects (^90 years) in Dujiangyan district (2005), only 563 women and 269 men were included finally in this study, which could introduce potential selection bias. Third, we still lack adjustment for other potential confounders, such as socio-economic status, duration of hypertension, family history of hypertension and the general health of the subjects. Most of all (90%) participants lived in the countryside in the present study. So far, some subjects have been working in farm every day, so physical activity may be a potential confounder. Thus this population may not be representative of the urban population. Finally, we could not include insulin resistance or serum insulin levels available. Therefore the socio- economic status, family history, dietary habits, lifestyles, insulin resistance or insulin sensitivity should be incorporated into future studies.
In conclusion, we found no direct association between serum uric acid level and hypertension in nonagenarians/centenarians. It could imply potential age-specific strategies focused on disease prevention as well as treatment in elder hypertensive patients, especially the oldest old. And future larger studies with a prospective setting are warranted concerning the physiological and clinical consequences of serum uric acid in the old subjects.
